Question 1

Does Morgan Stanley own KYTX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Morgan Stanley holds 982,307 shares of KYTX (Kyverna Therapeutics), worth $8.8M.

Question 2

How many shares of KYTX does Morgan Stanley own?

Accepted Answer

As of its Q2 2026 13F, Morgan Stanley holds 982,307 shares of KYTX (Kyverna Therapeutics).

Question 3

What is Morgan Stanley's KYTX position worth?

Accepted Answer

As of its Q2 2026 13F, Morgan Stanley's KYTX position is worth $8.8M.

Question 4

Is Morgan Stanley buying or selling KYTX?

Accepted Answer

In Q2 2026, Morgan Stanley increased its KYTX position by 5,018 shares (+0.5%).

Question 5

When did Morgan Stanley first buy KYTX?

Accepted Answer

Morgan Stanley already held KYTX in its Q2 2024 13F, the earliest on record, and has listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	982,307	+0.5%	$8.8M	0.0%	$8.91	28
2026-Q1	Decreased	977,289	-2.5%	$8.4M	0.0%	$8.63	0
2025-Q4	Increased	1M	+475.5%	$9.4M	0.0%	$9.40	45
2025-Q3	Decreased	174,203	-13.8%	$1M	0.0%	$6.00	0
2025-Q2	Increased	202,038	+49.8%	$620,257	0.0%	$3.07	23
2025-Q1	Decreased	134,910	-32.7%	$260,376	0.0%	$1.93	0
2024-Q4	Increased	200,594	+67.5%	$750,222	0.0%	$3.74	36
2024-Q3	Increased	119,794	+0.4%	$585,793	0.0%	$4.89	17
2024-Q2	First report	119,283	-	$894,623	0.0%	$7.50	0

KYTX9 quarters

KYTX
9 quarters